Home
Storia in 1 fonti
What's Going On With AbbVie Stock Friday? - AbbVie (NYSE:ABBV)
AbbVie shares are edging higher Friday following Thursday's positive Phase 3 trial results for its menstrual migraine drug, atogepant.
Raccontata da
benzinga.com
Timeline cronologica
- ·
AbbVie Drug Shows Significant Reductions in Menstrual Migraine Days - AbbVie (NYSE:ABBV)
AbbVie reported positive Phase 3 LUNA study results for atogepant, proving its efficacy and safety in preventing menstrual migraines.
- ·
What's Going On With AbbVie Stock Friday? - AbbVie (NYSE:ABBV)
AbbVie shares are edging higher Friday following Thursday's positive Phase 3 trial results for its menstrual migraine drug, atogepant.